What is Pituitary cancer Market?
Pituitary cancer is a rare form of cancer and only a few hundred cases are recorded globally. This disease is identified in elderly population and 75% of the pituitary cancer cases are diagnosed after the death of the individual. As per the American Brain Tumor Association, benign tumor accounted for 30% to 40% of the total pituitary tumor cases. This tumor is mostly diagnosed in women and men aged between 40 years and 50 years. One from every four people is estimated to suffer from benign pituitary tumor (adenoma), which is non-cancerous. Most pituitary tumors are benign and treatable. Pituitary tumors account for 12% to 19% of the total primary brain tumors.
The market study is being classified by Type (Surgery, Endoscopic Transnasal Transsphenoidal Surgery, Craniotomy, Radiation Therapy, Stereotactic Radiosurgery, External beam radiation, Intensity Modulated Radiation Therapy (IMRT), Proton Beam Therapy, Chemotherapy and Others), by Application (Hospital, Clinics, Diagnostic Centers and Research Institutes) and major geographies with country level break-up.
Amgen Inc. (United States), Bristol-Myers Squibb Company (United States), Celgene Corporation (United States), Eli Lilly and Company (United States), Astellas Pharma Inc. (Japan), Merck & Co., Inc.(United States), Novartis AG (Switzerland), Pfizer Inc. (United States), AstraZeneca (United Kingdom), Mylan N.V. (United States), Johnson & Johnson Services, Inc. (United States) and Onxeo (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ipsen Pharmaceuticals (France), Salix Pharmaceuticals, Inc. (United States) and Strides Pharma Science Limited (India).
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Pituitary cancer market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Pituitary cancer market by Type, Application and Region.
On the basis of geography, the market of Pituitary cancer has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Awareness regarding various Types of Cancer, including Pituitary Cancer
- Growing Incidence Rate of Pituitary Cancer
- Increasing R&D in the Field of Oncology
- Side Effects of the Treatment
- Rising R&D Activities for the Development of Advanced Treatment Options
- Increase in Ongoing Clinical Trials for Developing Treatment for Pituitary Cancer
- Stringent Government Regulations
On March 23, 2019, Corcept Therapeutics Incorporated announced a new website CushingResearch.com to support the recruitment in the phase 3 trial (called "GRACE") for Corcept’s proprietary compound relacorilant to treat the patients with Cushing’s syndrome., and On January 03, 2019, Cydan announced the launch of Tiburio Therapeutics Inc., which focused on developing treatments for rare neuroendocrine tumors and rare endocrine diseases
Key Target AudienceBiotechnology companies, Research institutes, Medical device companies, Pharmaceutical companies, Hospitals and clinics, Ambulatory surgical centers, Academic institutes and Government organizations
Frequently Asked Questions (FAQ):
1. Which factors would majorly drive the Pituitary cancer Market?
"Increasing Awareness regarding various Types of Cancer, including Pituitary Cancer
" is seen as one of major growth factors of Pituitary cancer Market in years to come.
2. Can we have customized study for Pituitary cancer Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.